Check Claims Before You Publish

 Quick Explanation Copied

 Long Explanation

Citation Footprint and Research Trajectory

Rodriguez-Raecke has 50 works with ~1,747 citations and an h-index of 16 per OpenAlex. Her citation profile is heavily concentrated in the chronic-pain structural plasticity era (2009–2014), driven by two J. Neurosci./NeuroImage papers Chronic pain gray matter reversibility (J. Neurosci., 536 cites) Trigeminal neuralgia VBM (NeuroImage, 240 cites). Recent output (2025–2026) shows renewed activity but negligible accrued citations so far.

Core Scientific Strengths

• Flagship contribution (chronic pain plasticity): The 2009 J. Neurosci. paper — first-authored, in Arne May's group — reframed gray-matter loss in chronic pain as a reversible consequence rather than damage, a field-shaping idea with 536 citations; limitations were small longitudinal subgroup (n=10) and uncorrected voxelwise thresholds, transparently acknowledged Reversible gray matter changes in chronic pain.
• Pain habituation psychophysiology: Rigorous, hypothesis-driven work distinguishing within-session sensitization from between-session habituation to repeated heat pain, with expectation/insula modulation Sensitization vs habituation to repeated heat pain Insula and negative expectation on pain habituation.
• Sensory neuroscience breadth: Controlled olfactory, gustatory, and multisensory fMRI studies, e.g., double-blind placebo-controlled intranasal insulin showing salience-network engagement in 26 lean men (crossover design, preregistered-quality controls, but male-only, small-n, restricted data) Intranasal insulin engages salience network and naturalistic distraction reducing taste intensity/pleasantness without attenuating gustatory cortex (n=42, 2x2x2 design, transparent null ROI results) Distracted eating fMRI study.

Blindspots and Uncertainties

Most studies are small-n human fMRI/behavioral work susceptible to low statistical power and sampling bias; replication of several findings would strengthen them. Correlative cross-sectional imaging (e.g., PET/DTI in PKAN or encephalitis) cannot establish causation, and recent 2025–2026 output has too few citations to assess impact. The citation record is concentrated in a single 2009–2014 burst — whether recent work will reach similar influence remains unknown.

 BGPT Author Review

Scientific Quality

Solid mid-career neuroscientist. One genuinely influential, field-shaping first-author finding (reversible chronic-pain gray matter changes) plus a coherent, hypothesis-driven body of pain/olfaction/multisensory work published in respectable venues (J. Neurosci., NeuroImage, Pain). h-index 16 with ~1,747 citations over ~50 papers is respectable but not exceptional; impact is concentrated in one burst. Most studies are small-n human neuroimaging with acknowledged confounds; no world-class methodological innovations apparent.

Communication Quality

Titles are clear and descriptive; limitations are transparently reported (small longitudinal subgroups, uncorrected thresholds). Work is accessible and well-structured, but mostly conventional study framing without notable outreach or pedagogical contributions visible in the record.

Author Novelty

The 2009 reversibility claim was conceptually bold and influential at the time. Subsequent work is competent but largely incremental — applying standard fMRI/VBM paradigms to pain, olfaction, insulin, and distraction. The 2026 distracted-eating study is reasonably fresh in ecological validity but builds on known attention-taste effects.

Scientific Rigor

Good rigor: within-subject crossover designs, control groups, acknowledged confounds, some preregistered-adjacent reporting and null-result honesty (e.g., no insula distraction effect reported). Deductions for small samples, uncorrected voxelwise thresholds, correlative designs, restricted data sharing, and reliance on single-institution cohorts.